» Articles » PMID: 28112459

Deep Sedation Vs. General Anesthesia in 232 Patients Undergoing Percutaneous Mitral Valve Repair Using the MitraClip System

Overview
Date 2017 Jan 24
PMID 28112459
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate in a series of 232 patients whether the MitraClip procedure can be performed safely using deep sedation (DS) without general anesthesia (GA).

Background: Transcatheter mitral valve repair using the MitraClip system is a safe and effective therapy for severe mitral regurgitation (MR) in patients who are at high operative risk or are unsuitable for surgery. For these patients, avoidance of GA might be beneficial.

Methods: Between 2011 and 2015, we performed 232 MitraClip procedures for the treatment of severe MR. Of those, 76 procedures were performed using GA, while the remaining 156 procedures were performed using DS.

Results: Age, logistic EuroScore, severity of MR, left and right ventricular function, and renal function did not differ between the groups. The primary combined safety endpoint, which was defined as the occurrence of major adverse cardiac and cerebrovascular events, conversion to surgery, major vascular complications or pneumonia, did not differ between MitraClip procedures performed using GA and MitraClip procedures performed using DS. Intraprocedural conversion to GA was required in 2% of the patients in the DS group. There were no differences in procedural success or clinical outcome between the groups at the 3-month follow-up. Preparation time in the catheterization laboratory and intensive care unit (ICU) stay were shorter in the DS group compared to the GA group.

Conclusion: The MitraClip implantation performed using DS is as safe and effective as MitraClip implantation performed using GA. © 2017 Wiley Periodicals, Inc.

Citing Articles

Frailty, periinterventional complications and outcome in patients undergoing percutaneous mitral and tricuspid valve repair.

Schafer M, Noth H, Metze C, Iliadis C, Korber M, Halbach M Clin Res Cardiol. 2024; .

PMID: 38358418 DOI: 10.1007/s00392-024-02397-3.


Valve unit instead of intensive or intermediate care unit admission following transcatheter edge-to-edge mitral valve repair is safe and reduces postprocedural complications.

Groger M, Felbel D, Paukovitsch M, Schneider L, Markovic S, Rottbauer W Clin Res Cardiol. 2024; .

PMID: 38353680 DOI: 10.1007/s00392-024-02384-8.


Anaesthesia for transcatheter mitral valve repair.

Dryden A, Hynes M, Hibbert B BJA Educ. 2023; 23(5):189-195.

PMID: 37124172 PMC: 10140472. DOI: 10.1016/j.bjae.2023.01.004.


Deep sedation vs. general anesthesia for transcatheter tricuspid valve repair.

Haurand J, Kavsur R, Ochs L, Tanaka T, Iliadis C, Sugiura A Front Cardiovasc Med. 2022; 9:976822.

PMID: 36119730 PMC: 9471949. DOI: 10.3389/fcvm.2022.976822.


Early Pacemaker Implantation after Transcatheter Aortic Valve Replacement: Impact of PlasmaBlade™ for Prevention of Device-Associated Bleeding Complications.

Lind A, Ahsan M, Kaya E, Wakili R, Rassaf T, Janosi R Medicina (Kaunas). 2021; 57(12).

PMID: 34946276 PMC: 8707306. DOI: 10.3390/medicina57121331.